Reviewed by Peptide Treatments Medical Advisory Board
Sermorelin: Side Effects & Safety
Known side effects, safety considerations, and adverse reaction data for Sermorelin.
Back to Sermorelin overviewData source: Side effects are based on FDA-approved labeling for related indications.
Reported Side Effects (6 items)
| # | Side Effect |
|---|---|
| 1 | Injection site reactions — redness, pain, or swelling (10-15%) |
| 2 | Headache — reported in 5-10% of users |
| 3 | Nausea — less than 5% incidence |
| 4 | Flushing — less than 5%, typically transient |
| 5 | Dizziness — less than 5% incidence |
| 6 | No serious adverse events identified in clinical trials |
Known Drug Interactions
Important: Only documented and contraindicated interactions are shown here. View all interactions including theoretical →
| Drug | Classification | Mechanism |
|---|---|---|
| glucocorticoids | Documented | May reduce GH response to GHRH stimulation |
| somatostatin analogs | Documented | Directly inhibits GHRH-mediated GH release |
| GHRP peptides | Documented | Synergistic GH release — may combine but monitor for excess |
| GH therapy | Documented | Additive GH effects — avoid concurrent use |